Duke logo

TPE in Heparin-Induced Thrombocytopenia (HIT) - Clinical Trial

What is the Purpose of this Study?

We are doing this study is to understand how TPE (therapeutic plasma exchange) can help to decrease blood-clotting risk in patients.

What is the Condition Being Studied?

Heparin-induced thrombocytopenia (HIT)

Who Can Participate in the Study?

Adult men and women who are:
- Receiving unfractionated heparin (UFH) or low molecular weight heparin (LMWH).

Age Group

What is Involved?

If you choose to join this study, you will:
- Participate in the study for about 30 days
- Provide blood samples throughout the study

Study Details

Full Title
Defining the Role of Therapeutic Plasma Exchange in Heparin Induced Thrombocytopenia
Principal Investigator
Protocol Number
Contact the Duke Recruitment Innovation Center